• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of December 5, 2012

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Source Plasma
Recall Number B-0093-13
Classification Class II
Code Info 0111149111; 0111147834; 0111146858; 0111145398; 0111144544; 0111140295; 0111139418; 0111137586; 0111136853; 0111135164; 0111132473; 0111110562; 0111108783; 0111108007; 0111105480; 0111104143; 0111103129; 0111101609; 0111100446; 0111098621; 0111097833; 0111096140; 0111094912; 0111093305; 0111092212; 0111090898; 0111089695; 0111086002; 0111084770; 0111083520; 0111082406; 0111081158; 0111079979; 0111078736; 8750013927; 8750012649; 8750011299; 8750009785; 8750008278; 8750007210; 8750005857; 8750003894; 8750000361; 0111072791; 0111070491; 0111069856; 0111066340; 0111065204; 0111062461; 0111061817; 0111057970; 0111056553; 0111053550; 0111052886.
Product Distributed Qty 54 Units
Reason For Recall Blood products, which were collected from a donor in which donor suitability were not adequately determined, were distributed

Event Detail

Event Id 55397
Product Type Biologics
Status Terminated
Recalling Firm CSL Plasma, Inc.
City Kansas City
State MO
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2010-01-12
Initial Firm Notification of Consignee or Public Other
Distribution Pattern Illinois; North Carolina; Germany; Switzerland
-
-